XML 45 R35.htm IDEA: XBRL DOCUMENT v3.22.4
Stock-Based Compensation (Tables)
 6 Months Ended
Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]  
Summary of Incentive Awards The activity related to the Company’s incentive equity awards for the three months ended December 31, 2022 consisted of the following:
Stock OptionsTime-based
Restricted Stock Units		Performance-based
Restricted Stock Units
Number of
Options		Weighted-
Average
Exercise
Price		Number
of Shares		Weighted-
Average
Grant
Date Fair
Value		Number
of Shares		Weighted-
Average
Grant
Date Fair
Value
Balances at September 30, 20222,328,936 $106.58 723,961 $135.65 205,906 $148.74 
Granted28,172 133.74 314,418 137.41 104,443 138.52 
Exercise of stock options (a)(31,864)69.55 — — — — 
Vesting of restricted stock units
— — (3,527)150.38 (2,887)164.08 
Expired/forfeited(2,745)144.84 (13,332)146.80 (790)165.05 
Balances at December 31, 2022 (b),(c)
2,322,499 $107.38 1,021,520 $136.00 306,672 $145.07 
(a)Stock options exercised during the period of October 1, 2022 through December 31, 2022 had an aggregate intrinsic value of $2.4 million.
(b)As of December 31, 2022, the Company’s outstanding vested and currently exercisable stock options using the December 31, 2022 closing stock price of $134.13 (approximately 1.4 million shares) had an aggregate intrinsic value of $64.8 million with a weighted-average exercise price of $89.25 and a weighted-average remaining contractual life of 4.8 years. The total of all stock options outstanding as of December 31, 2022 has a weighted-average remaining contractual life of 6.1 years.
(c)As of December 31, 2022, time-based restricted stock units and performance-based restricted stock units expected to vest using the December 31, 2022 closing stock price of $134.13 (approximately 1.0 million and 0.3 million shares, respectively) had an aggregate intrinsic value of $130.0 million and $38.3 million, respectively. Performance-based restricted stock units granted in the table above represent initial target awards, and performance adjustments for (i) change in shares issued based upon attainment of performance goals determined in the period, and (ii) estimated change in shares issued resulting from attainment of performance goals to be determined at the end of the prospective performance period.
The activity related to the Company’s incentive equity awards for the six months ended December 31, 2022 consisted of the following:
Stock OptionsTime-based
Restricted Stock Units		Performance-based
Restricted Stock Units
Number of
Options		Weighted-
Average
Exercise
Price		Number
of Shares		Weighted-
Average
Grant
Date Fair
Value		Number
of Shares		Weighted-
Average
Grant
Date Fair
Value
Balances at June 30, 20222,706,685 $102.34 750,852 $135.94 210,281 $148.59 
Granted28,172 133.74 326,883 138.64 105,861 138.90 
Exercise of stock options (a)(409,613)75.66 — — — — 
Vesting of restricted stock units
— — (26,314)155.14 (5,384)164.08 
Expired/forfeited(2,745)144.84 (29,901)146.61 (4,086)141.11 
Balances at December 31, 2022
2,322,499 $107.38 1,021,520 $136.00 306,672 $145.07 
(a)Stock options exercised during the period of July 1, 2022 through December 31, 2022 had an aggregate intrinsic value of $39.7 million.